Skeletal muscle density is an independent predictor of diffuse large B‐cell lymphoma outcomes treated with rituximab‐based chemoimmunotherapy

BACKGROUND: While much cancer research focuses on tumours and their microenvironment, malignancies cause widespread physiologic changes. Cancer and treatment‐related sarcopenia, measured with quantitative imaging or as a decrease in overall body mass, are indicative of poor prognosis in elderly diff...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Michael P., Lieffers, Jessica, Ghosh, Sunita, Belch, Andrew, Chua, Neil S., Fontaine, Amelie, Sangha, Randeep, Turner, Robert A., Baracos, Vickie E., Sawyer, Michael B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5377388/
https://www.ncbi.nlm.nih.gov/pubmed/27897411
http://dx.doi.org/10.1002/jcsm.12161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5377388/
https://www.ncbi.nlm.nih.gov/pubmed/27897411
http://dx.doi.org/10.1002/jcsm.12161

Ejemplares similares